Mark Rothera agreed to step down as chief commercial officer of PTC Therapeutics Inc., effective Aug. 9.
Rothera entered into a consulting agreement, effective Aug. 10, 2017, with a term continuing through Sept. 30, 2018.
PTC Therapeutics chief commercial officer stepping down
COVID-19 Pandemic Likely To Cause US Telemedicine Boom
Gauging Supply Chain Risk In Volatile Times
Cannabis: Hashing Out a Budding Industry
IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help
PTC Therapeutics chief commercial officer stepping down
- Author Mirza Salam Ahmed
- Theme Healthcare & Pharmaceuticals
- Author
- Mirza Salam Ahmed
- Theme
- Healthcare & Pharmaceuticals